Expert Radar
Dr. Gary Schiller, MD, FACP
Researcher, UCLA Jonsson Comprehensive Cancer Center
Bachelor of Science, University of Southern California
Dr. Gary J. Schiller has 32 years of experience in Hematologic Oncology and Hematology. He earned his BS in Biological Sciences from the University of Southern California and his MD from Keck School of Medicine of the University of Southern California. He completed his internship and residency in Internal Medicine, as well as his fellowship in Hematology and Oncology at David Geffen School of Medicine at UCLA. Today, this expert is board-certified in Hematology, Internal Medicine, and Medical Oncology by the American Board of Internal Medicine. Formerly, this expert was an Associate Professor of Medicine at David Geffen School of Medicine at UCLA and the Director of the Hematological Malignancies and Stem Cell Transplantation Unit at Ronald Reagan UCLA Medical Center. Currently, he serves as a Professor in the Department of Medicine’s Division of Hematology/Oncology at David Geffen School of Medicine at UCLA and as a Physician and the Director of the Bone Marrow/Stem Cell Transplant Program at Ronald Reagan UCLA Medical Center.
g*********@******.ucla
(310) ***-****
Los Angeles, California
Get a FREE Demo of Dr. Gary Schiller, MD, FACP's Radar Profile
Review this expert's litigation history, supporting legal docs, publications, professional background, and more.
Comprehensive data on expert witnesses: Access detailed litigation history and performance metrics.
Swift assessment: Quickly evaluate an expert's track record.
Informed decisions: Make better choices when selecting or challenging expert witnesses in any case.
Expert Witness Activity
Plaintiff Cases
Defense Cases
Expert Challenges
Deposition Transcripts
Publications
257
Media & News
858
Social Media Mentions
Expert Institute operates independently and objectively as an expert witness data provider. Expert Institute does not employ, endorse, or have an affiliation with any expert witnesses for which data is provided.
Case Name | Role | Filed Date |
---|---|---|
Gayle Cox, et al. v. High Desert Medical Group, et al. | Expert Witness | 2002-12-12 |
Radar monitors both national and state court systems to track litigation activity and access court documents.
View case details, documents, plaintiff and defense representation, defendants, judges, jurisdiction, and more.
Defense
Plaintiff
0
25
50
75
100
2000
0
2002
0
2004
0
2006
0
2008
0
2010
0
0
25
50
75
100
Radar found 257 records
Title | Type |
---|---|
Diminished durability of chimeric antigen receptor T-cell efficacy with severe or prolonged postinfusion cytopenias | Journal Article |
Diminished Durability of Chimeric Antigen Receptor T-Cell Efficacy with Severe or Prolonged Postinfusion Cytopenias | Letter |
Pomalidomide, Dexamethasone, And Daratumumab Immediately After Lenalidomide-Based Treatment in Patients with Multiple Myeloma: Updated Efficacy, Safety, And Health-Related Quality of Life Results From the Phase 2 Mm-014 Trial | Journal Article |
Radar monitors a wide array of publication sources, including links to abstracts.
Review book chapters, journal articles, research papers, trade publications, technical reports, conference proceedings, and more.
Radar found 858 records
Title | Description |
---|
Radar scours thousands of media and news sources across the internet 24/7.
Access interviews, webinars, TV appearances, blog posts, columns, whitepapers, PDFs, profressional profiles, and more.
Institution | Degree Type |
---|---|
University of Southern California | Bachelor of Science |
Keck School of Medicine at the University of Southern California | Doctor of Medicine |
Title | Employer |
---|---|
Researcher | UCLA Jonsson Comprehensive Cancer Center |
Director | Ronald Reagan UCLA Medical Center |
Director | UCLA Center for the Health Sciences |
Access detailed litigation history and performance metrics.
Access your Radar profile through Expert iQ, our secure, cloud-based platform that hosts AI-driven insights.
Delivered in 5–7 business days
Receive your profile swiftly, with Radar gathering intelligence from thousands of data points.
24/7 monitoring for 12 months
Stay informed with continuous monitoring and live alerts, ensuring your profile is always up-to-date.